Wiltshire, United Kingdom

Yorick Kamlag

This inventor holds 1 USPTO granted patent. Top assignee: Vectura Gmbh. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yorick Kamlag. Retrieved from https://idiyas.com/inventor/yorick-kamlag-52fpd3p4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yorick Kamlag: Innovator in Pulmonary Disease Treatment

Introduction

Yorick Kamlag is a notable inventor based in Wiltshire, GB. He has made significant contributions to the field of pulmonary medicine, particularly through his innovative work on mucoactive agents. His research focuses on addressing diseases characterized by excess mucus in the respiratory tract.

Latest Patents

Yorick Kamlag holds a patent for "Mucoactive agents for treating a pulmonary disease." This invention relates to the use of mucoactive agents, such as heparin, which are beneficial in treating conditions like cystic fibrosis and chronic obstructive pulmonary disease. The patent emphasizes pharmaceutical compositions designed for administration via pulmonary inhalation. Additionally, it outlines methods for producing particles suitable for this form of inhalation, utilizing techniques such as spray drying or jet milling. He has 1 patent to his name.

Career Highlights

Kamlag is associated with Vectura GmbH, where he continues to advance his research in pulmonary treatments. His work has the potential to significantly improve the quality of life for patients suffering from respiratory diseases.

Collaborations

Yorick collaborates with esteemed colleagues, including David Morton and David Ganderton, who contribute to his research endeavors.

Conclusion

Yorick Kamlag's innovative work in developing mucoactive agents represents a significant advancement in the treatment of pulmonary diseases. His contributions are poised to make a lasting impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…